Perfusion CT as a Predictor of Treatment Response in Patients With Rectal Cancer

Trial ID or NCT#

NCT01460641

Status

not recruiting iconNOT RECRUITING

Purpose

A research study of rectal cancer perfusion (how blood flows to the rectum over time). We hope to learn whether perfusion characteristics of rectal masses may be predictive of response to treatment and whether rectal perfusion characteristics can be used to follow response to treatment.

Official Title

Perfusion CT as a Predictor of Treatment Response in Patients With Rectal Cancer

Eligibility Criteria

Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Show Less

Investigator(s)

Teri A Longacre
Teri A Longacre
Pathologist, Surgical pathologist, Immunodiagnosis pathologist
Richard L. Kempson, MD, Professor in Surgical Pathology
Aya Kamaya
Aya Kamaya
Radiologist
Professor of Radiology (Body Imaging)

Contact us to find out if this trial is right for you.

Contact

Laura Gable
650-736-0798

View on ClinicalTrials.gov